Abstract
An evaluation of iron metabolism has been carried out in 23 untreated patients with Hodgkin's disease and 6 patients with other lymphomata. The reduction in red cell life span is related to the stage of the disease. There is an almost universal impairment of iron release from the reticuloendothelial system with a consequent sideropenia and failure of iron delivery to the bone marrow for erythropoiesis. This defect is found in all stages of the disease and is not related to systemic symptoms.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Beamish, M., Jones, P., Trevett, D. et al. Iron Metabolism in Hodgkin's Disease. Br J Cancer 26, 444–452 (1972). https://doi.org/10.1038/bjc.1972.61
Issue Date:
DOI: https://doi.org/10.1038/bjc.1972.61
This article is cited by
-
An integrative knowledge graph for rare diseases, derived from the Genetic and Rare Diseases Information Center (GARD)
Journal of Biomedical Semantics (2020)
-
Roles of iron in neoplasia
Biological Trace Element Research (1992)
-
Malignant disease: nutritional implications of disease and treatment
Cancer and Metastasis Review (1987)
-
Iron metabolism during infection and neoplasia
CANCER AND METASTASIS REVIEW (1987)
-
Das Serumferritin in der Differentialdiagnose der Anämie
Klinische Wochenschrift (1982)